| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Metaps Inc
Metaps Inc
TSE:6172
Metaps Inc
Cash Equivalents
Metaps Inc
Cash Equivalents Peer Comparison
4686
4733
3994
4443
3923
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Metaps Inc
TSE:6172
|
Cash Equivalents
¥12.3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Justsystems Corp
TSE:4686
|
Cash Equivalents
¥84.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
30%
|
CAGR 10-Years
23%
|
|
|
Obic Business Consultants Co Ltd
TSE:4733
|
Cash Equivalents
¥151.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Money Forward Inc
TSE:3994
|
Cash Equivalents
¥30.8B
|
CAGR 3-Years
59%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Sansan Inc
TSE:4443
|
Cash Equivalents
¥21.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Rakus Co Ltd
TSE:3923
|
Cash Equivalents
¥7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
See Also
What is Metaps Inc's Cash Equivalents?
Cash Equivalents
12.3B
JPY
Based on the financial report for Mar 31, 2023, Metaps Inc's Cash Equivalents amounts to 12.3B JPY.
What is Metaps Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
8%
Over the last year, the Cash Equivalents growth was 10%. The average annual Cash Equivalents growth rates for Metaps Inc have been 24% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
